List of works - Elda Tagliabue

"Omics" and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas.

scientific article published on 18 November 2014

Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab

scientific article published on 27 August 2014

Activation of NK cell cytotoxicity by aerosolized CpG-ODN/poly(I:C) against lung melanoma metastases is mediated by alveolar macrophages.

scientific article published on 5 January 2017

Activity and resistance of trastuzumab according to different clinical settings.

scientific article published on 02 July 2011

Alteration of laminin production in small-cell lung carcinoma: possible correlation with the absence of the basement membrane

scientific article published on January 1993

Antibody-induced activation of p185HER2 in the human lung adenocarcinoma cell line Calu-3 requires bivalency

scientific article published on June 1993

Antibody-mediated blockade of JMJD6 interaction with collagen I exerts antifibrotic and antimetastatic activities.

scientific article published on 8 August 2017

Antitumor efficacy of trastuzumab in nude mice orthotopically xenografted with human pancreatic tumor cells expressing low levels of HER-2/neu

scientific article

Ascites Regression and Survival Increase in Mice Bearing Advanced-stage Human Ovarian Carcinomas and Repeatedly Treated Intraperitoneally With CpG-ODN

scientific article published on 01 January 2010

Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study.

scientific article published on 27 April 2016

Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98).

scientific article

Biology, prognosis and response to therapy of breast carcinomas according to HER2 score

scientific article published on 9 June 2008

Breast cancer and microRNAs: therapeutic impact.

scientific article published on October 2011

Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers.

scientific article published on 28 September 2016

Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation.

scientific article published on 3 March 2017

Characterization of a monoclonal antibody directed against the epidermal growth factor receptor binding site

scientific article published on 01 January 1991

Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.

scientific article published in March 1987

Characterization of two monoclonal antibodies directed against the 67 kDa high affinity laminin receptor and application for the study of breast carcinoma progression

scientific article published on November 1992

Co-regulation and Physical Association of the 67-kDa Monomeric Laminin Receptor and the α6β4 Integrin

scientific article published on 01 January 1997

Combined targeting of EGFR and HER2 against prostate cancer stem cells

scientific article published on 23 February 2020

Correspondence

scientific article published on 01 November 1998

CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts.

scientific article published on 25 January 2016

Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation

scientific article published on 28 June 2019

Diadenosines as FHIT-ness instructors

scientific article

Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer

scientific article published on 18 September 2018

Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up.

scientific article published on 31 January 2014

ECM Remodelling in Breast Cancer with Different Grade: Contribution of 2D-DIGE Proteomics

scientific article published on 01 December 2018

EGFR through STAT3 modulates ΔN63α expression to sustain tumor-initiating cell proliferation in squamous cell carcinomas.

scientific article

ELISA assay employing epitope-specific monoclonal antibodies to quantify circulating HER2 with potential application in monitoring cancer patients undergoing therapy with trastuzumab

scientific article published on 20 February 2020

Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit

scientific article published on 27 November 2018

Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study

scientific article published on 13 August 2013

Elements Related to Heterogeneity of Antibody-Dependent Cell Cytotoxicity in Patients Under Trastuzumab Therapy for Primary Operable Breast Cancer Overexpressing Her2

scientific article published on 01 December 2007

Exploiting poly(I:C) to induce cancer cell apoptosis.

scientific article published on 7 September 2017

Expression and prognostic significance of the autoimmune regulator gene in breast cancer cells

scientific article published on 18 October 2016

Expression of Bone Sialoprotein in Human Lung Cancer

scientific article published on 01 September 1997

Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death

scientific article published on 09 February 2019

Expression profile of tyrosine phosphatases in HER2 breast cancer cells and tumors.

scientific article published in January 2010

Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment

scientific article published on 13 February 2020

Extracellular matrix proteins as diagnostic markers of breast carcinoma

scientific article published on 09 March 2018

Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.

scientific article published in February 2008

FHIT-proteasome degradation caused by mitogenic stimulation of the EGF receptor family in cancer cells

scholarly article

FOXP3 expression and overall survival in breast cancer.

scientific article published on 2 March 2009

FOXP3 expression in tumor cells and implications for cancer progression.

scientific article published on January 2013

Fhit Nuclear Import Following EGF Stimulation Sustains Proliferation of Breast Cancer Cells.

scientific article

Folate in head and neck squamous cell cancer chemoprevention: purposely left out?

scientific article published in July 2008

HER-2: a biomarker at the crossroads of breast cancer immunotherapy and molecular medicine.

scientific article

HER2 as a target for breast cancer therapy.

scientific article published on May 2010

HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy

scientific article published on 21 September 2018

Heregulin β1 induces the down regulation and the ubiquitin-proteasome degradation pathway of p185HER2 oncoprotein

scientific article published on 01 January 1998

Human Renal Antigen Defined by a Murine Monoclonal Antibody2

scientific article published on 01 August 1984

Human carcinoma cell lines xenografted in athymic mice: biological and antigenic characteristics of an intraabdominal model

article

Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD).

scientific article

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.

scientific article published on 11 April 2011

Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulation

scientific article

Induction of Paneth cell degranulation by orally administered Toll-like receptor ligands

scientific article published on 01 March 2012

Infiltrating mast cell-mediated stimulation of estrogen receptor activity in breast cancer cells promotes the luminal phenotype

scientific article published on 16 March 2020

Influence of Antibiotic Treatment on Breast Carcinoma Development in Proto-neu Transgenic Mice

article

Influence of fatty acid-free diet on mammary tumor development and growth rate in HER-2/Neu transgenic mice

scientific article published in January 2013

Influence of lignans depletion on murine mammary gland morphology.

scientific article published in January 2010

Inhibition of the Wnt Signalling Pathway: An Avenue to Control Breast Cancer Aggressiveness

scientific article published on 28 November 2020

Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting

scientific article published on 30 October 2018

International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).

scientific article published on January 2011

Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer

scientific article published on 21 August 2018

Linking survival of HER2-positive breast carcinoma patients with surgical invasiveness

scientific article published on 18 April 2006

Local Administration of Caloric Restriction Mimetics to Promote the Immune Control of Lung Metastases

scientific article published on 20 June 2019

Maspin influences response to doxorubicin by changing the tumor microenvironment organization.

scientific article published on 30 November 2013

Matured human monocyte-derived dendritic cells (MoDCs) induce expansion of CD4+CD25+FOXP3+ T cells lacking regulatory properties

scientific article published on 07 February 2008

Mexican <i>Ganoderma Lucidum</i> Extracts Decrease Lipogenesis Modulating Transcriptional Metabolic Networks and Gut Microbiota in C57BL/6 Mice Fed with a High-Cholesterol Diet

scientific article published on 24 December 2020

MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab.

scientific article

MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer

scientific article published on 12 August 2020

MicroRNA co-expression patterns unravel the relevance of extra cellular matrix and immunity in breast cancer.

scientific article published on 26 March 2018

MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.

scientific article

Modulation of DNA repair genes induced by TLR9 agonists: A strategy to eliminate "altered" cells?

scientific article published on March 2012

Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases

scientific article published on 01 September 2018

Molecular cytogenetic characterization of stem-like cancer cells isolated from established cell lines

scientific article

Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtype.

scientific article published on 18 March 2015

Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress

scientific article published on 18 February 2013

Nerve Growth Factor Cooperates with p185HER2in Activating Growth of Human Breast Carcinoma Cells

scientific article published on 01 February 2000

New basic discoveries and frontiers in diagnosis, prognosis and prediction of response to therapy in human thyroid, urinary bladder, and prostate tumors.

scientific article published in March 2004

New insights into the role of extracellular matrix during tumor onset and progression.

scientific article

Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer.

scientific article published on 19 April 2012

PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells

scientific article published on 27 March 2014

PET Prediction of Response to Trastuzumab in ErbB2-Positive Human Xenograft Model

scientific article published on 23 August 2012

Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer

scientific article

Peptide G, Containing the Binding Site of the 67-kDa Laminin Receptor, Increases and Stabilizes Laminin Binding to Cancer Cells

scientific article published on 01 December 1996

Pilot Study of the Mechanism of Action of Preoperative Trastuzumab in Patients with Primary Operable Breast Tumors Overexpressing HER2

scientific article published on 01 September 2004

Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas.

scientific article published on 26 March 2014

Poly(I:C) and CpG-ODN combined aerosolization to treat lung metastases and counter the immunosuppressive microenvironment

scientific article

Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy

scientific article published on February 2012

Predicting the Efficacy of HER2-Targeted Therapies: A Look at the Host.

scientific article

Predictive biomarkers in the treatment of HER2-positive breast cancer: an ongoing challenge

scientific article published on 23 March 2016

Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients

article

Prognostic role of tumor size in T1 HER2-positive breast cancers treated with adjuvant trastuzumab

scientific article published on 20 February 2014

Prognostic significance of laminin production in relation with its receptor expression in human breast carcinomas.

scientific article published on August 1995

Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas.

scientific article published on March 1993

Protein kinase Calpha determines HER2 fate in breast carcinoma cells with HER2 protein overexpression without gene amplification

scientific article published on June 2007

Quantification of Circulating Cancer Biomarkers via Sensitive Topographic Measurements on Single Binder Nanoarrays.

scientific article published on 13 June 2017

Radiation effects on development of HER2-positive breast carcinomas

scientific article published on January 2007

Regulation of breast cancer response to chemotherapy by fibulin-1.

scientific article published on May 2007

Relationship between p53 and p27 expression following HER2 signaling

scientific article

Relevance of Antibody Valency in EGF Receptor Modulation

scientific article published on 01 May 1994

Replacement of Fhit in cancer cells suppresses tumorigenicity

scientific article

Reprogramming the lung microenvironment by inhaled immunotherapy fosters immune destruction of tumor

scientific article published on 20 September 2016

Ricin A Chain Conjugated With Monoclonal Antibodies Selectively Killing Human Carcinoma Cells In Vitro2

scientific article published on 01 November 1985

Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients.

scientific article published on 22 February 2011

Role of HER2 in wound-induced breast carcinoma proliferation.

scientific article published in August 2003

Role of HER2/neu in tumor progression and therapy

scientific article

Role of exon-16-deleted HER2 in breast carcinomas

scientific article published on March 2006

Salad vegetables dietary pattern protects against HER-2-positive breast cancer: a prospective Italian study

scientific article published on August 2007

Secondary electrospray ionization-mass spectrometry and a novel statistical bioinformatic approach identifies a cancer-related profile in exhaled breath of breast cancer patients: a pilot study

scientific article published on 21 September 2015

Shed HER2 extracellular domain in HER2-mediated tumor growth and in trastuzumab susceptibility

scientific article

Sodium glucose cotransporter 1 ligand BLF501 as a novel tool for management of gastrointestinal mucositis.

scientific article published on 05 February 2014

Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34⁺ cells in a xenograft model

scientific article

TLR3 Expression Induces Apoptosis in Human Non-Small-Cell Lung Cancer

scientific article published on 20 February 2020

TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects.

scientific article

Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition.

scientific article published on 21 November 2015

The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO study

scientific article published on 05 July 2019

The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1.

scientific article published in June 2005

The HER2 World: Better Treatment Selection for Better Outcome

scientific article published on 01 January 2011

The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer.

scientific article published on 23 May 2018

The d16HER2 Splice Variant: A Friend or Foe of HER2-Positive Cancers?

scientific article published on 28 June 2019

The early relapse of premenopausal patients after surgery for node-positive breast carcinoma

scientific article published in November 2001

The human splice variant Δ16HER2 induces rapid tumor onset in a reporter transgenic mouse.

scientific article

The landscape of d16HER2 splice variant expression across HER2-positive cancers

scientific article published on 05 March 2019

The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy

scientific article published on 23 January 2020

Toll-like receptor 3 as a new marker to detect high risk early stage Non-Small-Cell Lung Cancer patients

scientific article published on 03 October 2019

Triple-negative breast cancer: present challenges and new perspectives

scientific article published on 24 April 2010

Tumor Extracellular Matrix Remodeling: New Perspectives as a Circulating Tool in the Diagnosis and Prognosis of Solid Tumors

scientific article published on 23 January 2019

Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers

scientific article

Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression

scientific article

Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab

scientific article published on 10 March 2009

WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer

scientific article published on 31 January 2019

Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltration

scientific article

cIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cells.

scientific article published on 19 April 2018

miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response.

scientific article published on 25 November 2015

p53-dependent downregulation of metastasis-associated laminin receptor

scientific article published on October 2002

List of works by Elda Tagliabue

"Omics" and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas.

Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab

Activation of NK cell cytotoxicity by aerosolized CpG-ODN/poly(I:C) against lung melanoma metastases is mediated by alveolar macrophages.

Activity and resistance of trastuzumab according to different clinical settings.

Alteration of laminin production in small-cell lung carcinoma: possible correlation with the absence of the basement membrane

Antibody-induced activation of p185HER2 in the human lung adenocarcinoma cell line Calu-3 requires bivalency

Antibody-mediated blockade of JMJD6 interaction with collagen I exerts antifibrotic and antimetastatic activities.

Antitumor efficacy of trastuzumab in nude mice orthotopically xenografted with human pancreatic tumor cells expressing low levels of HER-2/neu

Ascites Regression and Survival Increase in Mice Bearing Advanced-stage Human Ovarian Carcinomas and Repeatedly Treated Intraperitoneally With CpG-ODN

Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study.

Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98).

Biology, prognosis and response to therapy of breast carcinomas according to HER2 score

Breast cancer and microRNAs: therapeutic impact.

Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers.

Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation.

Characterization of a monoclonal antibody directed against the epidermal growth factor receptor binding site

Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.

Characterization of two monoclonal antibodies directed against the 67 kDa high affinity laminin receptor and application for the study of breast carcinoma progression

Co-regulation and Physical Association of the 67-kDa Monomeric Laminin Receptor and the α6β4 Integrin

Combined targeting of EGFR and HER2 against prostate cancer stem cells

Correspondence

CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts.

Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation

Diadenosines as FHIT-ness instructors

Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer

Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up.

ECM Remodelling in Breast Cancer with Different Grade: Contribution of 2D-DIGE Proteomics

EGFR through STAT3 modulates ΔN63α expression to sustain tumor-initiating cell proliferation in squamous cell carcinomas.

ELISA assay employing epitope-specific monoclonal antibodies to quantify circulating HER2 with potential application in monitoring cancer patients undergoing therapy with trastuzumab

Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit

Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study

Elements Related to Heterogeneity of Antibody-Dependent Cell Cytotoxicity in Patients Under Trastuzumab Therapy for Primary Operable Breast Cancer Overexpressing Her2

Exploiting poly(I:C) to induce cancer cell apoptosis.

Expression and prognostic significance of the autoimmune regulator gene in breast cancer cells

Expression of Bone Sialoprotein in Human Lung Cancer

Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death

Expression profile of tyrosine phosphatases in HER2 breast cancer cells and tumors.

Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment

Extracellular matrix proteins as diagnostic markers of breast carcinoma

Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.

FHIT-proteasome degradation caused by mitogenic stimulation of the EGF receptor family in cancer cells

FOXP3 expression and overall survival in breast cancer.

FOXP3 expression in tumor cells and implications for cancer progression.

Fhit Nuclear Import Following EGF Stimulation Sustains Proliferation of Breast Cancer Cells.

Folate in head and neck squamous cell cancer chemoprevention: purposely left out?

HER-2: a biomarker at the crossroads of breast cancer immunotherapy and molecular medicine.

HER2 as a target for breast cancer therapy.

HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy

Heregulin β1 induces the down regulation and the ubiquitin-proteasome degradation pathway of p185HER2 oncoprotein

Human Renal Antigen Defined by a Murine Monoclonal Antibody2

Human carcinoma cell lines xenografted in athymic mice: biological and antigenic characteristics of an intraabdominal model

Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD).

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.

Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulation

Induction of Paneth cell degranulation by orally administered Toll-like receptor ligands

Infiltrating mast cell-mediated stimulation of estrogen receptor activity in breast cancer cells promotes the luminal phenotype

Influence of Antibiotic Treatment on Breast Carcinoma Development in Proto-neu Transgenic Mice

Influence of fatty acid-free diet on mammary tumor development and growth rate in HER-2/Neu transgenic mice

Influence of lignans depletion on murine mammary gland morphology.

Inhibition of the Wnt Signalling Pathway: An Avenue to Control Breast Cancer Aggressiveness

Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting

International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).

Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer

Linking survival of HER2-positive breast carcinoma patients with surgical invasiveness

Local Administration of Caloric Restriction Mimetics to Promote the Immune Control of Lung Metastases

Maspin influences response to doxorubicin by changing the tumor microenvironment organization.

Matured human monocyte-derived dendritic cells (MoDCs) induce expansion of CD4+CD25+FOXP3+ T cells lacking regulatory properties

Mexican <i>Ganoderma Lucidum</i> Extracts Decrease Lipogenesis Modulating Transcriptional Metabolic Networks and Gut Microbiota in C57BL/6 Mice Fed with a High-Cholesterol Diet

MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab.

MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer

MicroRNA co-expression patterns unravel the relevance of extra cellular matrix and immunity in breast cancer.

MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.

Modulation of DNA repair genes induced by TLR9 agonists: A strategy to eliminate "altered" cells?

Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases

Molecular cytogenetic characterization of stem-like cancer cells isolated from established cell lines

Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtype.

Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress

Nerve Growth Factor Cooperates with p185HER2in Activating Growth of Human Breast Carcinoma Cells

New basic discoveries and frontiers in diagnosis, prognosis and prediction of response to therapy in human thyroid, urinary bladder, and prostate tumors.